Johnson & Johnson Consumer and Personal Products Worldwide

Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.

Phase 4
Completed
Conditions
Pain
First Posted Date
2005-10-18
Last Posted Date
2011-06-29
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
483
Registration Number
NCT00240838

A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee

First Posted Date
2005-10-18
Last Posted Date
2015-06-19
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
581
Registration Number
NCT00240773

An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain.

Phase 4
Completed
Conditions
Pain
Interventions
Drug: Acetaminophen
Drug: Ibuprofen
Drug: Placebo
First Posted Date
2005-10-18
Last Posted Date
2015-06-19
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
222
Registration Number
NCT00240825

An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain

Phase 4
Completed
Conditions
Pain
Interventions
Drug: placebo
Drug: acetaminophen
Drug: ibuprofen
First Posted Date
2005-10-18
Last Posted Date
2015-06-19
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
224
Registration Number
NCT00240864

An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.

First Posted Date
2005-10-18
Last Posted Date
2015-06-19
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
542
Registration Number
NCT00240799

An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race

Phase 4
Completed
Conditions
Pain
Interventions
Drug: acetaminophen extended release
First Posted Date
2005-10-18
Last Posted Date
2015-06-19
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
665
Registration Number
NCT00240851

Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash

First Posted Date
2005-09-22
Last Posted Date
2011-08-22
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
112
Registration Number
NCT00219466
Locations
🇺🇸

JJCPPW Investigational Site, St. Petersburg, Florida, United States

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

Phase 3
Completed
Conditions
Androgenetic Alopecia
Interventions
Drug: minoxidil
First Posted Date
2005-09-09
Last Posted Date
2016-09-30
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
352
Registration Number
NCT00151515
Locations
🇺🇸

Pfizer Investigational Site, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy